William Blair initiated coverage on Solid Biosciences with a new price target
$SLDB
Biotechnology: Biological Products (No Diagnostic Substances)
Health Care
William Blair initiated coverage of Solid Biosciences with a rating of Outperform and set a new price target of $40.00